Nonopioid and nonpharmacologic pain management coverage provided by health plans requirement provision
Impact
The enactment of SF1946 would significantly reshape state laws concerning health insurance coverage for pain management. It prohibits health plans from favoring opioid prescriptions over nonopioid alternatives, thereby attempting to ensure that patients have access to a broader range of treatment options without being steered toward potentially addictive medications. Additionally, the educational requirements for health plans emphasize transparency and improve patient awareness of available treatments, which could lead to more informed healthcare decisions.
Summary
Senate File 1946 mandates that health insurance plans must provide coverage for nonopioid and nonpharmacologic options for pain management. The bill recognizes the growing concern about opioid abuse and aims to promote alternative treatments as effective pain management solutions. It requires health plans to offer at least two alternative prescription drugs that are FDA-approved and not classified as controlled substances, along with three nonpharmacologic, nonoperative modalities to manage pain. This approach attempts to shift the paradigm of pain management toward safer options and reduce reliance on opioids.
Contention
One potential point of contention regarding SF1946 may arise from the healthcare industry’s response to the mandated coverage and the prohibitions on utilization controls for nonopioid treatments. Some stakeholders may argue that these requirements could complicate the operational framework of health plans and may lead to increased costs. Furthermore, while proponents advocate that the bill will reduce opioid dependency, skeptics might question the effectiveness and adequacy of nonopioid alternatives in managing pain across diverse patient populations.
Requires insurers to develop plans for coverage and access to nonnarcotic, nonopioid and nonmedication pain management for moderate to severe pain. It further restricts utilization review for nonopioid drugs.
A bill for an act relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers' development of a pain management access plan.
A bill for an act relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers' development of a pain management access plan.